How is coronavirus affecting our operations? Learn more

drugs

Print this page

Drug candidates may block cell death in Parkinson’s disease

Science Daily reports that in a pair of related studies, scientists from the Florida campus of The Scripps Research Institute (TSRI) have shown their drug candidates can target biological pathways involved in the destruction of brain cells in Parkinson’s disease. The studies, published in the Journal of Medicinal Chemistry and Scientific Reports, suggest that it…

Print this page Print this page

Exenatide may be disease-modifying for PD

Exenatide is a type 2 diabetes treatment that has been shown to have neuroprotective/neurorestorative properties in preclinical models of neurodegeneration. A new study by Aviles-Olmos et al published in the Journal of Clinical Investigation reports on the results of a trial to evaluate the progress of 45 patients with moderate Parkinson’s disease (PD). Single-blinded rating…

Print this page Print this page

Medication Workshop

A very successful and well-attended medication workshop was held on Wednesday 22 February 2012. Discussions were led by Alison Stewart, Senior Parkinson’s Nurse at the Royal Victoria Hospital, and Alison Thomson, Senior Clinical Pharmacist in the Department of Neurosciences at the Western General Hospital, Edinburgh.  The flyer for the meeting is here: Seminar_on_Medication (PDF)

Print this page